A new study links changes in frailty, a measure of decreased physiological capacity that leads to fatigue, slow walking, muscle weakness, physical inactivity, and weight loss, to five-year survival rates in older women with breast cancer. These findings suggest that managing frailty during chemotherapy could improve outcomes.
Leave A Comment